Oracea (Doxycycline)

Doxycycline, the active ingredient in Oracea, is a tetracycline antibiotic presented as a 40 mg delayed‑release tablet for oral use. It treats inflammatory lesions of rosacea in adults, including persistent facial erythema and papulopustular eruptions, by providing anti‑inflammatory and antibacterial effects.

GNH USA supplies Oracea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to European Union quality standards and offering reliable global distribution for regulated markets.

Oracea (doxycycline) is used to manage inflammatory skin conditions within the rosacea disease spectrum.

Rosacea (papulopustular): Reduces inflammatory papules and pustules, improving skin appearance. Erythematotelangiectatic rosacea: Decreases persistent facial redness and telangiectasia. Overall rosacea management: Improves skin texture and lowers lesion count, providing long‑term control of disease activity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools that may be transient. - Photosensitivity: increased skin sensitivity to sunlight. - Abdominal pain: cramping or discomfort. - Dyspepsia: indigestion or heartburn. - Vomiting: occasional emesis.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare but life‑threatening skin eruption. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Hepatotoxicity: liver enzyme elevations or injury. - Intracranial hypertension: headache and visual changes. - Severe skin reactions: toxic epidermal necrolysis or drug rash with eosinophilia and systemic symptoms.

Before initiating therapy, consider the following precautions: - Pregnancy: Use only if benefits outweigh risks (Category D). - Breastfeeding: Avoid unless essential; doxycycline is excreted in milk. - Renal impairment: Dose adjustment may be required in reduced kidney function. - Sun exposure: Counsel patients on photosensitivity; advise sunscreen and protective clothing. - Drug interactions: Review concomitant medications for potential interactions. - Store at ambient temperature: Keep below 25 °C, in the original pack, protect from moisture.

Oracea may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Isotretinoin or other oral retinoids: increased risk of intracranial hypertension. - Anticoagulants (e.g., warfarin): potentiation of anticoagulant effect, may raise INR.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: reduce doxycycline absorption; separate dosing by at least 2 hours. - Oral contraceptives: may diminish contraceptive efficacy; consider backup method. - Methotrexate: increased risk of hepatotoxicity and bone marrow suppression.